AGAPE ATP CORPORATION (ATPC) Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..
Cash and securities
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 45.48K USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $45.48K | (m) | (m) |
| 2026-03-31 | (m) | (m) | $220.78K | (m) | (m) |
| 2025-12-31 | (m) | (m) | $140.07K | (m) | (m) |
| 2025-09-30 | (m) | (m) | $133.71K | (m) | (m) |
| 2025-06-30 | (m) | (m) | $215.97K | (m) | (m) |
| 2025-03-31 | (m) | (m) | $578.79K | (m) | (m) |
| 2024-12-31 | (m) | (m) | $2.04M | (m) | (m) |
| 2024-09-30 | (m) | (m) | $2.72M | (m) | (m) |
| 2024-06-30 | (m) | (m) | $3.16M | (m) | (m) |
| 2024-03-31 | (m) | (m) | $3.58M | (m) | (m) |
| 2023-12-31 | (m) | (m) | $4.83M | (m) | (m) |
| 2023-09-30 | (m) | (m) | $311.66K | (m) | (m) |
| 2023-06-30 | (m) | (m) | $653.75K | (m) | (m) |
| 2023-03-31 | (m) | (m) | $1.12M | (m) | (m) |
| 2022-12-31 | (m) | (m) | $1.44M | (m) | (m) |
| 2022-09-30 | (m) | (m) | $1.58M | (m) | (m) |
| 2022-06-30 | (m) | (m) | $1.81M | (m) | (m) |
| 2022-03-31 | (m) | (m) | $2.44M | (m) | (m) |
| 2021-12-31 | (m) | (m) | $2.60M | (m) | (m) |
| 2021-09-30 | (m) | (m) | $2.88M | (m) | (m) |
| 2021-06-30 | (m) | (m) | $3.30M | (m) | (m) |
| 2021-03-31 | (m) | (m) | $3.35M | (m) | (m) |
| 2020-12-31 | (m) | (m) | $3.52M | (m) | (m) |
| 2020-09-30 | (m) | (m) | $3.34M | (m) | (m) |
| 2020-06-30 | (m) | (m) | $3.43M | (m) | (m) |
| 2020-03-31 | (m) | (m) | $2.59M | (m) | (m) |
| 2019-12-31 | (m) | (m) | $2.74M | (m) | (m) |
| 2019-09-30 | (m) | (m) | $2.75M | (m) | (m) |
| 2019-06-30 | (m) | (m) | $2.86M | (m) | (m) |
| 2019-03-31 | (m) | (m) | $3.09M | (m) | (m) |
| 2018-12-31 | (m) | (m) | $3.45M | (m) | (m) |
| 2018-09-30 | (m) | (m) | $3.84M | (m) | (m) |
| 2018-06-30 | (m) | (m) | $3.53M | (m) | (m) |
| 2018-03-31 | (m) | (m) | $4.11M | (m) | (m) |
| 2017-12-31 | (m) | (m) | $1.86M | (m) | (m) |
| 2017-09-30 | (m) | (m) | $2.16M | (m) | (m) |
| 2017-06-30 | (m) | (m) | $2.31M | (m) | (m) |
| 2016-12-31 | (m) | (m) | $10.00 | (m) | (m) |
| 2016-09-30 | (m) | (m) | $10.00 | (m) | (m) |
| 2016-06-30 | (m) | (m) | $10.00 | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |